Viewing Study NCT01563068


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-03-16 @ 7:59 AM
Study NCT ID: NCT01563068
Status: COMPLETED
Last Update Posted: 2018-05-11
First Post: 2012-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
Sponsor: Mayne Pharma International Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module